Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

MILIO, Glauco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.533
EU - Europa 2.604
AS - Asia 1.927
SA - Sud America 293
AF - Africa 45
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.410
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.482
SG - Singapore 658
IT - Italia 579
CN - Cina 576
RU - Federazione Russa 504
UA - Ucraina 366
FI - Finlandia 284
DE - Germania 236
BR - Brasile 235
HK - Hong Kong 209
VN - Vietnam 147
GB - Regno Unito 120
IE - Irlanda 119
PL - Polonia 118
FR - Francia 106
JP - Giappone 77
SE - Svezia 53
IN - India 44
KR - Corea 39
TR - Turchia 30
BE - Belgio 27
BD - Bangladesh 26
NL - Olanda 25
IQ - Iraq 23
CA - Canada 19
MX - Messico 18
AR - Argentina 17
CH - Svizzera 17
ZA - Sudafrica 16
RO - Romania 14
CI - Costa d'Avorio 12
VE - Venezuela 12
PK - Pakistan 11
IR - Iran 10
MY - Malesia 10
AT - Austria 9
ES - Italia 9
UZ - Uzbekistan 9
BO - Bolivia 6
ID - Indonesia 6
NP - Nepal 6
PY - Paraguay 6
SA - Arabia Saudita 6
AU - Australia 5
CO - Colombia 5
LB - Libano 5
MA - Marocco 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
DZ - Algeria 4
IL - Israele 4
BH - Bahrain 3
CR - Costa Rica 3
EC - Ecuador 3
GR - Grecia 3
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
LT - Lituania 3
PH - Filippine 3
PT - Portogallo 3
UY - Uruguay 3
AM - Armenia 2
GE - Georgia 2
HR - Croazia 2
OM - Oman 2
PA - Panama 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BW - Botswana 1
CU - Cuba 1
DK - Danimarca 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
NZ - Nuova Zelanda 1
PE - Perù 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.410
Salva come PNG Salva come JPEG
Città #
Ashburn 439
Singapore 421
Chandler 279
Fairfield 222
San Jose 211
Hong Kong 201
Jacksonville 199
Ann Arbor 170
Woodbridge 163
Wilmington 142
Dublin 119
Houston 114
Zgierz 105
Medford 86
Des Moines 79
Seattle 78
Nanjing 77
Tokyo 76
Frankfurt am Main 74
Cambridge 71
Moscow 71
Santa Clara 68
Palermo 66
Beijing 64
New York 57
Princeton 53
Hefei 52
Los Angeles 52
Tulsa 50
Ho Chi Minh City 49
Lauterbourg 45
Boardman 43
Hanoi 37
Council Bluffs 34
Dearborn 29
Buffalo 28
Dallas 28
Milan 27
Brussels 26
Jinan 25
San Diego 24
Shenyang 24
Rome 22
Altamura 21
Hebei 21
Changsha 20
Helsinki 20
Nanchang 20
San Mateo 20
Jiaxing 19
The Dalles 18
Izmir 17
Orem 17
Chicago 14
São Paulo 14
Tianjin 14
Johannesburg 13
Lawrence 13
Seongnam 13
Abidjan 12
Columbus 12
Shanghai 12
Verona 12
Ningbo 11
Pune 11
Warsaw 11
Zhengzhou 11
Atlanta 10
Da Nang 10
Haiphong 10
Catania 9
Chennai 9
Ludwigshafen am Rhein 9
Maidstone 9
Munich 9
Auburn Hills 8
Baghdad 8
City of London 8
Phoenix 8
Taizhou 8
Amsterdam 7
Bari 7
Denver 7
Florence 7
Guangzhou 7
Lanzhou 7
London 7
Naples 7
Redondo Beach 7
Tehran 7
Cardiff 6
Detroit 6
Falls Church 6
Haikou 6
Kunming 6
New Delhi 6
Poplar 6
Rio de Janeiro 6
Venice 6
Affoltern am Albis 5
Totale 4.910
Salva come PNG Salva come JPEG
Nome #
Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol 284
Critical limb ischaemia: definition and natural hystory 274
Modello di percorso diagnostico e terapeutico per l'arteriopatia obliterante periferica 263
Asymptomatic carotid lesions and aging: role of hypertension and other traditional and emerging risk factors 245
Antiplatelet treatment in ischemic stroke treatment. 241
Ischemia critica cronica e vasculopatia ischemica polidistrettuale 240
Asymptomatic Carotid Lesions and Aging: Role of Hypertension and Other Traditional and Emerging Risk Factors 239
Subclavean stenosis/occlusion in patients with subclavean steal and previous by pass of internal mammary interventricular anterior artery: medical or surgery treatment? 238
Changes of arterial hemodynamics in patients with type 2 diabetes mellitus or impaired glucose tolerance 227
Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: The Duration of Anticoagulation based on Compression Ultrasonography (DACUS) study 193
Immunohistochemical expression of iNOS and metalloproteinases MMP2 and MMP9 in abdominal inflammatory aortic Aneurysms 190
Absence of residual vein thrombosis after an episode of idiopatic deep vein thrombosis: short-term anticoagulation is safe. The extended DACUS Study 187
Superficial venous thrombosis: Prevalence of common genetic risk factors and their role on spreading to deep veins 186
Pharmacological Treatment of Patients with Chronic Critical Limb Ischemia: L-Propionyl-Carnitine Enhances the Short-Term Effects of PGE-1 185
Calf vein thrombosis: optimal duration of treatment 180
Effetti dell’iloprost sulla disfunzione leucocitaria nella sclerodermia. 178
Modello di percorso diagnostico e terapeutico per la trombosi venosa superficiale 175
Efficacy of the treatment with prostaglandin E-1 in venous ulcers of the lower limbs 175
Comportamento della eNOS e dell'iNOS nella genesi e mantwnimento delle ulcere venose degli arti inferiori 169
Absence of residual vein thrombosis after an episode of idiopatic deep vein thrombosis: short-term anticoagulation is safe. The extended DACUS study. 165
Stress ossidativo in pazienti con sclerodermia: effetti dell’iloprost. 159
Response to letter by Drs. Mohammed Abbas, Maria Sessa, and Francesco Corea 157
La terapia metabolica nel trattamento dell'ischemia critica cronica degli arti inferiori: la L-propionilcarnetina potenzia gli effetti della PGE-1 154
MTHFR allele 677T band risk of abdominal aortic aneurysm 151
Calf vein thrombosis: optimal duration of tretment 151
Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial 151
Residual vein thrombosis assessment estabilishes the optimal duration of oral anticoagulants in patients with idiopatic or provoked deep vein thrombosis 150
Aspetti fisiopatologici dell'ulcera venosa 145
Effetti emoreologici del trattamento con iloprost in pazienti con fenomeno di Raynaud secondario a sclerodermia. 142
Moderno approccio alla trombosi venosa superficiale 142
Immunohistochemical expression of iNOS and eNOS in the venous ulcers related to chronic venous insufficiency (CVI). 140
Calf veins thrombosis: optimal duration of treatment 140
Residual vein thrombosis assessment establishes the otpimal duration of oral anticoagulants in patients with idiopathic or provoked deep vein thrombosis 139
Superficial venous thrombosis: role of genetic risk factors on spreeding to deep veins 137
Sodium thiosulfate not always resolves calciphylaxis: an ambiguous response 134
Residual Vein Thrombosis Assessment Establishes the Optimal Duration of Oral Anticoagulants in Patients with Idiopathic or Provoked Deep Vein Thrombosis: a Randomized, Controlled Trial 117
Residual vein thrombosis estabilishes the optimal duration of oral anticoagulants for the treatment od DVT 117
Metabolic therapy in the treatment of chronic critical limbs ischemia: the L-propionyl-carnitine enhances the effects of PGE-1 113
Trombosi venosa superficiale ed estensione al circolo profondo: ruolo dei fattori di rischio genetici 113
Trattamento delle manifestazioni vascolari nella Sclerosi Sistemica e qualità della vita: nuovo protocollo 111
THE EFFECTS OF PROSTAGLANDIN E-1 IN PATIENTS WITH INTERMITTENT CLAUDICATION 111
Ischemia critica e connettiviti: presupposti fisiopatologici per un protocollo di trattamento 110
Residual vein thrombosis assessment estabilishes the optimal duration of oral anticoagulants in patients with idiopatic or provoked deep vein thrombosis. a randomized, controlled trial 109
The effects Prostaglandine E-1 in patients with intermittent claudication 105
SUPERFICIAL VENOUS THROMBOSIS: ROLE OF GENETIC RISK FACTORS ON SPREADING TO DEEP VEINS 103
The effects of Prostaglandin E-1in patients with intermittent claudication 103
Superficial venous thrombosis and spreading to deep veins: role of genetic risk factors for venous thromboembolism 102
null 100
TROMBOSI PROFONDA SUPERFICIALE ED ESTENSIONE AL CIRCOLO PROFONDO: RUOLO DEI FATTORI DI RISCHIO GENETICI 100
Peso dei fattori di rischio nell’evoluzione dell’aterosclerosi preclinica 99
NO and Chronic Venous Insufficiency (CVI): Immunohistochemical Evaluation of iNOS and eNOS Isofroms in the Venous Ulcers. Clinical and Therapeutical Possible Implications 96
Il trattamento domiciliare della TVP 94
Rilievi emoreologici nella sclerosi sistemica. 93
METABOLIC THERAPY IN THE TREATMENT OF CHRONIC CRITICAL LIMBS ISCHEMIA OF THE LOWER LIMBS. THE L-PROPIONYL-CARNITINE ENHANCES THE EFFECTS OF PGE-1 88
null 57
Totale 8.467
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.691
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.691
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202164 0 0 0 0 0 0 0 0 0 0 0 64
2021/2022539 18 139 5 35 20 7 27 23 65 68 20 112
2022/2023762 82 97 9 87 86 117 64 63 94 16 41 6
2023/2024301 14 48 17 31 21 79 33 7 1 7 5 38
2024/2025882 19 54 30 109 55 22 99 73 56 70 91 204
2025/20263.070 190 54 182 256 270 444 393 338 185 610 127 21
Totale 8.467